Medicare to Pay Doctors More for Covid-19 Antibody Treatment (1)

May 6, 2021, 9:38 PM; Updated: May 7, 2021, 7:13 PM

The Medicare agency is bumping up payment of a Covid-19 antibody treatment to boost the underutilized therapy that has shown promise in keeping patients out of the hospital.

Providers can get $750 for bringing a treatment known as monoclonal antibodies to the patient either at their home, hotel, or whenever they’re staying. Infusion centers and other health-care settings offering the antibody treatment will see the average payment rate increase to $450. The Centers for Medicare & Medicaid Services said the changes take effect Thursday.

“Beginning on May 6, 2021, Medicare established separate coding and payment for administering COVID-19 monoclonal antibody ...

To read the full article log in.

Learn more about A Bloomberg Law subscription.